Intellia Therapeutics Inc (NTLA)
Cash & Short-Term Investments
$437.76M
Quarterly · Period ending: · USD
NTLA Cash & Short-Term Investments
Latest reported$437.76Mperiod ending
Latest reported$437.76Mperiod ending
NTLA Quarterly Cash & Short-Term Investments ($9.85M → $437.76M)
Quarterly Cash & Short-Term Investments
High-resolution chart · PNG
NTLA cash & short-term investments history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Short-Term Investments (USD) |
|---|---|
| 437,759,000 | |
| 375,986,000 | |
| 449,884,000 | |
| 511,044,000 | |
| 459,651,000 | |
| 503,747,000 | |
| 601,515,000 | |
| 658,114,000 | |
| 691,068,000 | |
| 791,294,000 | |
| 912,223,000 | |
| 854,788,000 | |
| 908,074,000 | |
| 933,542,000 | |
| 1,192,622,000 | |
| 828,194,000 | |
| 874,275,000 | |
| 855,251,000 | |
| 748,688,000 | |
| 798,267,000 | |
| 529,019,000 | |
| 584,063,000 | |
| 597,371,000 | |
| 407,947,000 | |
| 436,804,000 | |
| 250,259,000 | |
| 279,726,000 | |
| 285,922,000 | |
| 271,099,000 | |
| 296,582,000 | |
| 314,059,000 | |
| 293,248,000 | |
| 305,538,000 | |
| 327,778,000 | |
| 340,678,000 | |
| 222,264,000 | |
| 241,047,000 | |
| 257,551,000 | |
| 273,064,000 | |
| 290,618,000 | |
| 300,687,000 | |
| 64,192,000 | |
| 75,816,000 | |
| 82,612,000 | |
| 19,765,000 | |
| 9,845,000 | |
| 9,845,000 |